Showing results (1-10 of 288) with videos related to
Sort By:
Pageof 29
Cancer Research|September 1, 1980
Sensitivity of leukemic human null lymphocytes to deoxynucleosidesR M Fox, E H Tripp, S K Piddington, et al.The Journal of Clinical Investigation|August 1, 1981
Ecto-adenosine triphosphatase deficiency in cultured human T and null leukemic lymphocytes. A biochemical basis for thymidine sensitivityR M Fox, S K Piddington, E H Tripp, et al.Lancet (London, England)|August 25, 1979
Thymidine sensitivity of cultured leukaemic lymphocytesR M Fox, S K Piddington, E H Tripp, et al.Cancer Research|May 1, 1980
Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytesR M Fox, E H Tripp, M H TattersallMolecular Pharmacology|September 1, 1984
Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblastsR M Fox, E H Tripp, I W TaylorCancer Treatment Reports|January 1, 1981
Methotrexate treatment of advanced head and neck cancers: a dose response evaluationR L Woods, R M Fox, M H TattersallBiochimica Et Biophysica Acta|December 15, 1980
The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriationA A Piper, M H Tattersall, R M FoxCancer Treatment Reports|November 1, 1979
Treatment of small cell bronchogenic carcinoma with VM-26R L Woods, R M Fox, M H TattersallThe Medical Journal of Australia|December 15, 1979
Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycinR L Woods, R M Fox, M H TattersallBritish Medical Journal (Clinical Research Ed.)|February 21, 1981
Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluationR L Woods, R M Fox, M H TattersallPageof 29